[Cytolytic episodes during cirrhosis].
D000983:Antipyrine / Q000009:adverse effects / Q000031:analogs & derivatives; D001008:Anxiety Disorders / Q000188:drug therapy; D001463:Barbiturates / Q000009:adverse effects; D002110:Caffeine / Q000009:adverse effects; D002779:Cholestasis / Q000139:chemically induced* / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000473:pathology; D008376:Maprotiline / Q000009:adverse effects; D008875:Middle Aged; D012008:Recurrence; D013693:Temazepam / Q000009:adverse effects; D013997:Time Factors
D001463:Barbiturates; D008376:Maprotiline; D002110:Caffeine; D013693:Temazepam; D006220:Haloperidol; C004470:butalbital; C009077:propyphenazone; D000983:Antipyrine
Episodi citolitici in corso di cirrosi.